Tech Company Financing Transactions
Leading Pharma Funding Round
On 1/9/2018, Leading Pharma raised $40 million in financing from Signet Healthcare Partners, Cane Investments and Crestline Investors.
Transaction Overview
Company Name
Announced On
1/9/2018
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Undisclosed
Investors
Signet Healthcare Partners (Lead Investor) (Nikhil Puri)
Crestline Investors (Chris Semple)
Proceeds Purpose
The growth capital will be used to support Leading Pharma's research and development (R&D) investments in expanding the company's diverse pipeline of generic products and to repay existing indebtedness.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3 Oak Rd.
Fairfield, NJ 07004
USA
Fairfield, NJ 07004
USA
Phone
Website
Email Address
Overview
Leading Pharma, LLC is a privately owned generic pharmaceutical company that purchases, licenses, develops, manufactures and distributes high-quality, safe and effective products to drugstore chains, distributors, wholesalers, mass merchandisers, government agencies and managed care accounts in the U.S.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ronald Gold
Controller
Richard Monica
President
Rasik Gondalia
VP - Bus. Development
Brian Shapiro
VP - Finance
Karen O'Connor
VP - Operations
Anjanish Gondalia
Browse more venture capital transactions:
Prev: 1/9/2018: Metavention venture capital transaction
Next: 1/9/2018: Alveo Technologies venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document tech company VC transactions. VC investment data records on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs